MAIA Biotechnology, Inc.

MAIA · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$23,255-$19,773-$15,769-$12,578
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,913$3,089$2,319$2,723
Change in WC-$1,238$3,086$353$1,126
Other Non-Cash$6,875$527$1,001$4,607
Operating Cash Flow-$15,704-$13,071-$12,096-$4,123
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$7,431
Stock Issued$18,755$11,417$13,974$5,742
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$578-$2,146-$1,496$860
Financing Cash Flow$18,177$9,271$12,477$14,034
Forex Effect-$22-$0-$4$0
Net Chg. in Cash$2,451-$3,800$377$9,911
Supplemental Information
Beg. Cash$7,151$10,951$10,574$663
End Cash$9,601$7,151$10,951$10,574
Free Cash Flow-$15,704-$13,071-$12,096-$4,123